Gruia Gabriela has filed 4 insider transactions across 2 companies since June 2024.
Most recent transaction: a grant/award of 67000 shares of TScan Therapeutics, Inc. ($TCRX) on June 30, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2025 | TScan Therapeutics, Inc. | $TCRX | Gruia Gabriela | Not found | A | Stock Option (Right to Buy) | 67000 | $0.00 | 67,000.0000 | 111,990,417 | 9999.99% | 0.06% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Gruia Gabriela | Director | A | Common Stock | 1045 | $0.00 | 1,045.0000 | 5,993,866 | 9999.99% | 0.02% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Gruia Gabriela | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 12, 2024 | TScan Therapeutics, Inc. | $TCRX | Gruia Gabriela | Not found | A | Stock Option (Right to Buy) | 47500 | $0.00 | 47,500.0000 | 65,599,858 | 9999.99% | 0.07% |